4/22/2026 at 6:07:05 PM
Biologics production is one of the industries that is ripe for a manufacturing breakthrough, and would greatly benefit humanity.The current best option we have for combating heart disease and lowering cholesterol are monoclonal antibodies (PCSK9 inhibitors), and a similar trajectory is developing with sarcopenia and obesity biologics (Bimagrumab).
by gavinray
4/22/2026 at 8:51:08 PM
Manufacturability is treated as an afterthought right now, but as we’ve seen in other industries, if you can bring some of those constraints earlier into the process it can have serious economic implications.The opportunity for manufacturing innovation is growing, as the next generation of monoclonal antibodies are even more difficult to produce at scale.
by sterlinghooten